# Telithromycin in Respiratory Tract Infections

> **NCT00261105** · PHASE4 · COMPLETED · sponsor: **Sanofi**

## Conditions studied

- Respiratory Tract Infections

## Interventions

- **DRUG:** telithromycin

## Key facts

- **NCT ID:** NCT00261105
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-10
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261105, "Telithromycin in Respiratory Tract Infections". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00261105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*